- Home
- ACIU vs WBX Comparison
ACIU vs WBX Comparison
Compare ACIU & WBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACIU
- WBX
- Stock Information
- Founded
- ACIU 2003
- WBX 2015
- Country
- ACIU Switzerland
- WBX Spain
- Employees
- ACIU N/A
- WBX N/A
- Industry
- ACIU Biotechnology: Pharmaceutical Preparations
- WBX Industrial Specialties
- Sector
- ACIU Health Care
- WBX Consumer Discretionary
- Exchange
- ACIU Nasdaq
- WBX Nasdaq
- Market Cap
- ACIU 189.1M
- WBX 85.1M
- IPO Year
- ACIU 2016
- WBX N/A
- Fundamental
- Price
- ACIU $2.06
- WBX $5.90
- Analyst Decision
- ACIU Strong Buy
- WBX Buy
- Analyst Count
- ACIU 1
- WBX 3
- Target Price
- ACIU $12.00
- WBX $14.33
- AVG Volume (30 Days)
- ACIU 122.5K
- WBX 18.9K
- Earning Date
- ACIU 08-05-2025
- WBX 07-31-2025
- Dividend Yield
- ACIU N/A
- WBX N/A
- EPS Growth
- ACIU N/A
- WBX N/A
- EPS
- ACIU N/A
- WBX N/A
- Revenue
- ACIU $32,014,254.00
- WBX $171,352,140.00
- Revenue This Year
- ACIU N/A
- WBX N/A
- Revenue Next Year
- ACIU $533.21
- WBX $44.10
- P/E Ratio
- ACIU N/A
- WBX N/A
- Revenue Growth
- ACIU 91.20
- WBX 3.75
- 52 Week Low
- ACIU $1.43
- WBX $4.60
- 52 Week High
- ACIU $4.26
- WBX $32.80
- Technical
- Relative Strength Index (RSI)
- ACIU 54.21
- WBX 86.59
- Support Level
- ACIU $1.94
- WBX $0.29
- Resistance Level
- ACIU $2.15
- WBX $6.50
- Average True Range (ATR)
- ACIU 0.16
- WBX 0.21
- MACD
- ACIU -0.00
- WBX 0.54
- Stochastic Oscillator
- ACIU 72.22
- WBX 90.26
About ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses most of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
About WBX Wallbox N.V.
Wallbox NV is a smart electric vehicle charging and energy management company. It creates a smart charging system combining technology design that manages the communication between the user, vehicle, grid, building, and charger. The company designs, manufactures, and distributes faster, simpler EV charging solutions for residential, business, and public use. Its smart charging product portfolio includes Level 2 alternating current chargers for home and business applications and direct current fast chargers for public applications. The company has three reportable operating segments; Europe, Middle East and Asia (EMEA), its key revenue-generating segment, North America, and Asia-Pacific.